RadNet, Inc. Total Liabilities and Equity
RadNet, Inc. (RDNT) had Total Liabilities and Equity of $4.23 billion as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-08-10
- 2026-06-30: Liabilities and Equity $4.23B.
- 2026-03-31: Liabilities and Equity $3.89B.
- 2025-12-31: Liabilities and Equity $3.76B.
- 2025-09-30: Liabilities and Equity $3.67B.
| Period end | Liabilities and Equity | Liabilities and Equity as first filed |
|---|---|---|
| 2026-06-30 | $4.23B 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $3.89B 10-Q · filed 2026-05-11 | |
| 2025-12-31 | $3.76B 10-Q · filed 2026-08-10 | |
| 2025-09-30 | $3.67B 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $3.51B 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $3.34B 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $3.29B 10-K · filed 2026-03-02 | |
| 2024-09-30 | $3.28B 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $3.23B 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $2.97B 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $2.69B 10-K · filed 2025-03-03 | |
| 2023-09-30 | $2.69B 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $2.71B 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $2.41B 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $2.43B 10-K · filed 2024-02-29 | |
| 2022-09-30 | $2.25B 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $2.24B 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $2.14B 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $2.06B 10-K · filed 2023-03-01 | |
| 2021-09-30 | $2.04B 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $2.03B 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $1.83B 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $1.79B 10-K · filed 2022-03-01 | |
| 2020-09-30 | $1.72B 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $1.72B 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $1.70B 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $1.65B 10-K · filed 2021-03-16 | |
| 2019-09-30 | $1.62B 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $1.60B 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $1.53B 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $1.11B 10-K · filed 2020-03-16 | |
| 2018-09-30 | $910.64M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $912.98M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $923.63M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $868.98M 10-K · filed 2019-03-18 | |
| 2017-09-30 | $847.92M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $851.82M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $853.98M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $849.48M 10-K · filed 2018-03-19 | |
| 2016-09-30 | $843.40M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $828.34M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $845.71M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $35.49M 10-K/A · filed 2017-03-31 | $838.43M 10-K · filed 2016-03-15 |
| 2015-09-30 | $808.88M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $788.50M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $742.40M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $37.32M 10-K/A · filed 2016-03-30 | $740.68M 10-K · filed 2015-03-16 |
| 2014-09-30 | $748.52M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $738.45M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $737.24M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $40.65M 10-K/A · filed 2016-03-30 | $722.58M 10-K · filed 2014-03-17 |
| 2013-09-30 | $715.13M 10-Q · filed 2013-11-13 | |
| 2013-06-30 | $726.73M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $727.13M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $42.10M 10-K/A · filed 2014-03-31 | $715.12M 10-K · filed 2013-03-18 |
| 2012-09-30 | $625.01M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $627.61M 10-Q/A · filed 2012-08-30 | |
| 2012-03-31 | $626.28M 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $43.90M 10-K/A · filed 2013-11-13 | $619.19M 10-K · filed 2012-03-13 |
| 2011-09-30 | $572.23M 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $571.07M 10-Q · filed 2011-08-09 | |
| 2010-12-31 | $539.51M 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |